CHEK2 and prostate cancer: The CHEK2-associated hereditary cancer syndrome could include gastrointestinal tumors (colon and gastric cancer), prostate cancer, renal cancer, thyroid cancer, sarcomas, and hematological neoplasms (leukemia and plasma cell neoplasms) [28,38,47,48,49].